APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ivosidenib

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Ivosidenib Market Outlook and Growth Opportunities 2026

22 December 2025198 pages

Choose your research edition.

Industry ResearchIvosidenib Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Ivosidenib Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Ivosidenib Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ivosidenib Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Ivosidenib Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Ivosidenib market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Ivosidenib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Ivosidenib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Ivosidenib is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Ivosidenib market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Ivosidenib market include Servier Pharmaceuticals. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Ivosidenib market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Ivosidenib and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Ivosidenib sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Ivosidenib market size, projected growth trends, production technologies, key applications, and end-use industries.

Ivosidenib Segment by Company

Servier Pharmaceuticals

Ivosidenib Segment by Type

60 Tablets

30 Tablets

Ivosidenib Segment by Application

Hospital

Pharmacy

Ivosidenib Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Ivosidenib status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Ivosidenib market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Ivosidenib significant trends, drivers, influence factors in global and regions.

6. To analyze Ivosidenib competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ivosidenib market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ivosidenib and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ivosidenib.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Ivosidenib market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Ivosidenib industry.

Chapter 3: Detailed analysis of Ivosidenib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Ivosidenib in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Ivosidenib in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Ivosidenib Industry Trends Table 2. Ivosidenib Industry Drivers Table 3. Ivosidenib Industry Opportunities and Challenges Table 4. Ivosidenib Industry Restraints Table 5. Global Ivosidenib Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Ivosidenib Revenue Share by Company (2021-2026) Table 7. Global Ivosidenib Sales Volume by Company (units) & (2021-2026) Table 8. Global Ivosidenib Sales Volume Share by Company (2021-2026) Table 9. Global Ivosidenib Average Price (US$/unit) of Company (2021-2026) Table 10. Global Ivosidenib Company Ranking, (2024-2026) & (USD Million) Table 11. Global Ivosidenib Key Company Manufacturing Base & Headquarters Table 12. Global Ivosidenib Company, Product Type & Application Table 13. Global Ivosidenib Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Ivosidenib by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 60 Tablets Table 18. Significant Companies of 30 Tablets Table 19. Global Ivosidenib Sales Volume by Type 2021 VS 2025 VS 2032 (units) Table 20. Global Ivosidenib Sales Volume by Type (2021-2026) & (units) Table 21. Global Ivosidenib Sales Volume by Type (2027-2032) & (units) Table 22. Global Ivosidenib Sales Volume Share by Type (2021-2026) Table 23. Global Ivosidenib Sales Volume Share by Type (2027-2032) Table 24. Global Ivosidenib Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Ivosidenib Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Ivosidenib Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Ivosidenib Sales Value Share by Type (2021-2026) Table 28. Global Ivosidenib Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Pharmacy Table 31. Global Ivosidenib Sales Volume by Application 2021 VS 2025 VS 2032 (units) Table 32. Global Ivosidenib Sales Volume by Application (2021-2026) & (units) Table 33. Global Ivosidenib Sales Volume by Application (2027-2032) & (units) Table 34. Global Ivosidenib Sales Volume Share by Application (2021-2026) Table 35. Global Ivosidenib Sales Volume Share by Application (2027-2032) Table 36. Global Ivosidenib Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Ivosidenib Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Ivosidenib Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Ivosidenib Sales Value Share by Application (2021-2026) Table 40. Global Ivosidenib Sales Value Share by Application (2027-2032) Table 41. Global Ivosidenib Sales by Region: 2021 VS 2025 VS 2032 (units) Table 42. Global Ivosidenib Sales by Region (2021-2026) & (units) Table 43. Global Ivosidenib Sales Market Share by Region (2021-2026) Table 44. Global Ivosidenib Sales by Region (2027-2032) & (units) Table 45. Global Ivosidenib Sales Market Share by Region (2027-2032) Table 46. Global Ivosidenib Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Ivosidenib Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Ivosidenib Sales Value Share by Region (2021-2026) Table 49. Global Ivosidenib Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Ivosidenib Sales Value Share by Region (2027-2032) Table 51. Global Ivosidenib Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global Ivosidenib Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global Ivosidenib Sales by Country: 2021 VS 2025 VS 2032 (units) Table 54. Global Ivosidenib Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Ivosidenib Sales by Country (2021-2026) & (units) Table 56. Global Ivosidenib Sales Market Share by Country (2021-2026) Table 57. Global Ivosidenib Sales by Country (2027-2032) & (units) Table 58. Global Ivosidenib Sales Market Share by Country (2027-2032) Table 59. Global Ivosidenib Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Ivosidenib Sales Value Market Share by Country (2021-2026) Table 61. Global Ivosidenib Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Ivosidenib Sales Value Market Share by Country (2027-2032) Table 63. Servier Pharmaceuticals Company Information Table 64. Servier Pharmaceuticals Business Overview Table 65. Servier Pharmaceuticals Ivosidenib Sales (units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Servier Pharmaceuticals Ivosidenib Product Portfolio Table 67. Servier Pharmaceuticals Recent Development Table 68. Key Raw Materials Table 69. Raw Materials Key Suppliers Table 70. Ivosidenib Distributors List Table 71. Ivosidenib Customers List Table 72. Research Programs/Design for This Report Table 73. Authors List of This Report Table 74. Secondary Sources Table 75. Primary Sources List of Figures Figure 1. Ivosidenib Product Image Figure 2. Global Ivosidenib Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ivosidenib Sales Value (2021-2032) & (US$ Million) Figure 4. Global Ivosidenib Sales (2021-2032) & (units) Figure 5. Global Ivosidenib Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Ivosidenib Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 60 Tablets Image Figure 10. 30 Tablets Image Figure 11. Global Ivosidenib Sales Volume by Type (2021 VS 2025 VS 2032) & (units) Figure 12. Global Ivosidenib Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Ivosidenib Sales Volume Share by Type (2021-2032) Figure 14. Global Ivosidenib Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Ivosidenib Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Ivosidenib Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Pharmacy Image Figure 19. Global Ivosidenib Sales Volume by Application (2021 VS 2025 VS 2032) & (units) Figure 20. Global Ivosidenib Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Ivosidenib Sales Volume Share by Application (2021-2032) Figure 22. Global Ivosidenib Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Ivosidenib Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Ivosidenib Sales Value Share by Application (2021-2032) Figure 25. Global Ivosidenib Sales by Region: 2021 VS 2025 VS 2032 (units) Figure 26. Global Ivosidenib Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Ivosidenib Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Ivosidenib Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Ivosidenib Sales Value (2021-2032) & (US$ Million) Figure 30. North America Ivosidenib Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Ivosidenib Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Ivosidenib Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Ivosidenib Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Ivosidenib Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Ivosidenib Sales Value (2021-2032) & (US$ Million) Figure 36. South America Ivosidenib Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Ivosidenib Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Ivosidenib Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Ivosidenib Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Ivosidenib Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Ivosidenib Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Ivosidenib Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Ivosidenib Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 60 Tablets
  • 30 Tablets
Applications
  • Hospital
  • Pharmacy
Companies covered
  • Servier Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Ivosidenib Sales Value (2021-2032)
  4. 1.2.2 Global Ivosidenib Sales Volume (2021-2032)
  5. 1.2.3 Global Ivosidenib Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Ivosidenib Market Dynamics
  1. 2.1 Ivosidenib Industry Trends
  2. 2.2 Ivosidenib Industry Drivers
  3. 2.3 Ivosidenib Industry Opportunities and Challenges
  4. 2.4 Ivosidenib Industry Restraints
3 Ivosidenib Market by Company
  1. 3.1 Global Ivosidenib Company Revenue Ranking in 2025
  2. 3.2 Global Ivosidenib Revenue by Company (2021-2026)
  3. 3.3 Global Ivosidenib Sales Volume by Company (2021-2026)
  4. 3.4 Global Ivosidenib Average Price by Company (2021-2026)
  5. 3.5 Global Ivosidenib Company Ranking (2024-2026)
  6. 3.6 Global Ivosidenib Company Manufacturing Base and Headquarters
  7. 3.7 Global Ivosidenib Company Product Type and Application
  8. 3.8 Global Ivosidenib Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Ivosidenib Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Ivosidenib Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Ivosidenib Market by Type
  1. 4.1 Ivosidenib Type Introduction
  2. 4.1.1 60 Tablets
  3. 4.1.2 30 Tablets
  4. 4.2 Global Ivosidenib Sales Volume by Type
  5. 4.2.1 Global Ivosidenib Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Ivosidenib Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Ivosidenib Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Ivosidenib Sales Value by Type
  9. 4.3.1 Global Ivosidenib Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Ivosidenib Sales Value by Type (2021-2032)
  11. 4.3.3 Global Ivosidenib Sales Value Share by Type (2021-2032)
5 Ivosidenib Market by Application
  1. 5.1 Ivosidenib Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Pharmacy
  4. 5.2 Global Ivosidenib Sales Volume by Application
  5. 5.2.1 Global Ivosidenib Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Ivosidenib Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Ivosidenib Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Ivosidenib Sales Value by Application
  9. 5.3.1 Global Ivosidenib Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Ivosidenib Sales Value by Application (2021-2032)
  11. 5.3.3 Global Ivosidenib Sales Value Share by Application (2021-2032)
6 Ivosidenib Regional Sales and Value Analysis
  1. 6.1 Global Ivosidenib Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Ivosidenib Sales by Region (2021-2032)
  3. 6.2.1 Global Ivosidenib Sales by Region: 2021-2026
  4. 6.2.2 Global Ivosidenib Sales by Region (2027-2032)
  5. 6.3 Global Ivosidenib Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Ivosidenib Sales Value by Region (2021-2032)
  7. 6.4.1 Global Ivosidenib Sales Value by Region: 2021-2026
  8. 6.4.2 Global Ivosidenib Sales Value by Region (2027-2032)
  9. 6.5 Global Ivosidenib Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Ivosidenib Sales Value (2021-2032)
  12. 6.6.2 North America Ivosidenib Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Ivosidenib Sales Value (2021-2032)
  15. 6.7.2 Europe Ivosidenib Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Ivosidenib Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Ivosidenib Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Ivosidenib Sales Value (2021-2032)
  21. 6.9.2 South America Ivosidenib Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Ivosidenib Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Ivosidenib Sales Value Share by Country, 2025 VS 2032
7 Ivosidenib Country-level Sales and Value Analysis
  1. 7.1 Global Ivosidenib Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Ivosidenib Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Ivosidenib Sales by Country (2021-2032)
  4. 7.3.1 Global Ivosidenib Sales by Country (2021-2026)
  5. 7.3.2 Global Ivosidenib Sales by Country (2027-2032)
  6. 7.4 Global Ivosidenib Sales Value by Country (2021-2032)
  7. 7.4.1 Global Ivosidenib Sales Value by Country (2021-2026)
  8. 7.4.2 Global Ivosidenib Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Ivosidenib Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Ivosidenib Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Ivosidenib Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Ivosidenib Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Ivosidenib Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Ivosidenib Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Ivosidenib Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Ivosidenib Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Ivosidenib Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Ivosidenib Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Ivosidenib Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Ivosidenib Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Ivosidenib Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Ivosidenib Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Ivosidenib Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Ivosidenib Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Ivosidenib Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Ivosidenib Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Ivosidenib Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Ivosidenib Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Ivosidenib Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Ivosidenib Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Ivosidenib Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Ivosidenib Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Ivosidenib Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Ivosidenib Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Ivosidenib Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Ivosidenib Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Ivosidenib Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Ivosidenib Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Ivosidenib Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Ivosidenib Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Ivosidenib Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Ivosidenib Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Ivosidenib Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Ivosidenib Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Ivosidenib Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Ivosidenib Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Ivosidenib Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Ivosidenib Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Ivosidenib Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Ivosidenib Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Ivosidenib Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Ivosidenib Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Ivosidenib Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Ivosidenib Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Ivosidenib Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Ivosidenib Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Ivosidenib Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Ivosidenib Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Ivosidenib Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Ivosidenib Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Ivosidenib Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Ivosidenib Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Ivosidenib Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Ivosidenib Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Ivosidenib Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Ivosidenib Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Ivosidenib Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Ivosidenib Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Ivosidenib Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Ivosidenib Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Ivosidenib Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Ivosidenib Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Ivosidenib Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Ivosidenib Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Ivosidenib Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Ivosidenib Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Ivosidenib Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Ivosidenib Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Ivosidenib Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Ivosidenib Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Ivosidenib Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Ivosidenib Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Ivosidenib Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Ivosidenib Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Ivosidenib Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Ivosidenib Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Ivosidenib Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Ivosidenib Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Ivosidenib Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Ivosidenib Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Ivosidenib Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Ivosidenib Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Servier Pharmaceuticals
  2. 8.1.1 Servier Pharmaceuticals Company Information
  3. 8.1.2 Servier Pharmaceuticals Business Overview
  4. 8.1.3 Servier Pharmaceuticals Ivosidenib Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Servier Pharmaceuticals Ivosidenib Product Portfolio
  6. 8.1.5 Servier Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Ivosidenib Value Chain Analysis
  2. 9.1.1 Ivosidenib Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Ivosidenib Sales Mode & Process
  6. 9.2 Ivosidenib Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Ivosidenib Distributors
  9. 9.2.3 Ivosidenib Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst